MedResearch's Clinical Research Document Compliance

MedResearch is a contract research organization (CRO) managing clinical trial documentation for 20 pharmaceutical sponsors across 80 active studies. Each study generates approximately 50,000 documents including protocols, informed consent forms, case report forms, safety reports, and regulatory submissions. The company must comply with FDA 21 CFR Part 11 for electronic records and ICH E6 Good Clinical Practice guidelines. A recent FDA inspection found critical deficiencies: document version control failures resulted in three clinical sites using outdated versions of informed consent forms, electronic signatures did not meet Part 11 requirements, audit trails were incomplete for 15% of document modifications, and there was no systematic process for distributing updated documents to the 300 clinical sites participating in active studies. The Quality Director must remediate these findings within 6 months before the FDA re-inspection. Failure to remediate could result in clinical holds on active studies, affecting $200 million in sponsor revenue.